首页>投融资

ARTHEx Biotech

B轮

Arthex Biotech SL is a spin-off company of the University of Valencia, is developing antisense RNA treatments against genetic diseases.In May 2023, Arthex Biotech SA closed its €42 million Series B financing round.In July 2020, the company closed a funding round of Euro 4.25 million (US $4.9 million) and by which the total funds raised by Arthex since inception were now Euro 6.95 million (US $8 million)

https://www.arthexbiotech.com/

470180

基本信息

公司全称

ARTHEX Biotech SL
类型

创新药物研发商
产业领域

研发制造服务、生物/化学技术、药品研发/制造
公司人数

15人以下
地址

CALLE Catedr[tico Agustin Escardino Numero9 PATERNA VALENCIA; ES;
联系电话

+34 625 016 629
邮箱

info@arthexbiotech.com
成立时间

2019-01-01

投融资

2023-05-03

B轮

4200万欧元

European Innovation Council

Hadean Ventures

AdBio partners

Centre for the Development of Industrial Technology

Columbus Venture Partners

Invivo Capital

Sound Bioventures
2023-03-30

捐赠/众筹

未透露

European Innovation Council
2023-03-30

捐赠/众筹/授予

未透露

European Innovation Council
2020-07-27

未公开

425万欧元

Advent France Biotechnology

Invivo Capital
2020-07-27

未透露

425万欧元

Advent France Biotechnology

Invivo Capital
2020-07-14

未公开

120万欧元

Centre for the Development of Industrial Technology
2020-01-08

未公开

150万欧元

Invivo Capital
2020-01-08

未透露

150万欧元

Invivo Capital
加载更多

ARTHEx Biotech

基本信息

投融资

相关投融资企业